Carmot Therapeutics

Developer of drugs designed to unlock novel therapeutic target space not currently accessible to conventional small molecule technologies. The company’s drugs are made with proprietary Chemotype Evolution technology that helps in the rapid identification of novel drugs through an evolutionary lead-identification paradigm, enabling patients to cure metabolic diseases, cancer and inflammation.

Address:
740 Heinz Avenue
City:
Berkeley
Zip:
94710
Primary Contact:
Stig Hansen
Contact Number:
Website:
www.carmot.us